COMP <GO>
ULS vs UNH // OPTIONS IMPLIED MOVE & PUT/CALL SKEW
UL Solutions Inc. (NYSE) VS. UnitedHealth Group Incorporated (NYSE) • 15-METRIC TALLY: ULS 7
— UNH 7
■ METRIC PARITY
LAST: $75.46 (+4.23%) • MKT CAP: $15.24B
options-implied-move
—
LAST: $410.91 (+0.94%) • MKT CAP: $368.83B
options-implied-move
6.74%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ULS VS. UNH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ULS | UNH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 49.50% | 88.57% | -39.07 | UNH | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 28.30% | 11.47% | +16.83 | ULS | /roic <GO> |
| EV/EBITDA & P/E Valuation | 22.4x | 16.4x | +5.95 | UNH | /valuation <GO> |
| Free Cash Flow Yield | 2.65% | 6.48% | -3.83 | UNH | /fcf-yield <GO> |
| Operating Margin | 17.10% | 4.82% | +12.28 | ULS | /operating-margins <GO> |
| Net Profit Margin | 10.60% | 3.14% | +7.46 | ULS | /net-margins <GO> |
| Revenue Growth (YoY) | 6.40% | 6.46% | -0.06 | UNH | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.68% | 2.28% | -1.60 | UNH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 7.58 | 3.12 | +4.46 | ULS | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 7/9 | +1.00 | ULS | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew ACTIVE | — | 6.74% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 63.1 | 59.2 | +3.90 | ULS | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.08 | 0.33 | +0.75 | ULS | /macro-sensitivity <GO> |
| Forward P/E Multiple | 43.6x | 17.1x | +26.51 | UNH | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $15.24B | $368.83B | -$353.60B | UNH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ULS REV | UNH REV | ULS GROSS % | UNH GROSS % | ULS FCF | UNH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $3.05B | $447.57B | 49.5% | 88.7% | $403.0M | $16.07B |
| FY 2024 | $2.87B | $400.28B | 48.5% | 88.3% | $287.0M | $20.70B |
| FY 2023 | $2.68B | $371.62B | — | 89.6% | $346.5M | $25.68B |
| FY 2022 | — | $324.16B | — | 89.6% | — | $23.40B |
| FY 2021 | — | $287.60B | — | 89.2% | — | $19.89B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ULS // BETA 1.08
UNH // BETA 0.33